Organization
Inreda Diabetic
2 clinical trials
Clinical trial
A Stable Glucagon Analog Administered by a Bihormonal Closed Loop System; a Feasibility StudyStatus: Withdrawn, Estimated PCD: 2023-12-29
Clinical trial
Fully Automated Glycemic Control With Ultrarapid Insulin in a Bihormonal Closed Loop System in Patients With Type 1 DiabetesStatus: Completed, Estimated PCD: 2023-03-16